PUBLIC HEALTH e-ISSN 1643-3750 © Med Sci Monit, 2014; 20: 182-190 DOI: 10.12659/MSM.890019
Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania
Received: 2013.11.11 Accepted: 2013.12.13 Published: 2014.02.04
Authors’ Contribution: Study Design A Data Collection B Analysis C Statistical Data Interpretation D Manuscript Preparation E Literature Search F Collection G Funds
ABCDEF 1 AC 1 AD 1,2 DEF 3 BDF 4 BD 5
AF 1
AF 1
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
MeSH Keywords:
Full-text PDF:
Aldona Mikaliūkštienė Kęstutis Žagminas Algirdas Juozulynas Laura Narkauskaitė Jonas Sąlyga Konstancija Jankauskienė Rimantas Stukas Genė Šurkienė
1 Faculty of Medicine, Vilnius University, Vilnius, Lithuania 2 Department of Innovative Diagnostic, Treatment and Health Technology, Institute of Innovative Medicine, Vilnius, Lithuania 3 Department of Research and Technology Assassment, Institute of Hygiene, Vilnius, Lithuania 4 Faculty of Health Science, University of Klaipėda, Klaipėda, Lithuania 5 Academy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
Laura Narkauskaite, e-mail: [email protected] Departmental sources
Depression is associated with a variety of diabetes complications, including diabetic retinopathy, nephropathy, neuropathy, and macrovascular complications. The prevalence of the symptoms of anxiety (32%) and depression (22.4%) in patients with diabetes is considerably higher than in general population samples (10%). The aim of this study was to evaluate the prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes (T2DM). This survey was conducted during 2007-2010. In total, 1500 patients were invited to participate in the study. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety for the evaluation of the depressive state and anxiety. Statistical analysis was carried out using SPSS 17.0. More than 70% of all respondents who participated in the study had diabetes mellitus complications (72.2%). The prevalence of mild to severe depression score was 28.5% (95% CI 25.7–31.4). The prevalence of anxiety was 42.4% (95% CI 39.3–45.5). Anxiety was more frequent among females (46.8%) than among males (34.7%) (p
Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania
Received: 2013.11.11 Accepted: 2013.12.13 Published: 2014.02.04
Authors’ Contribution: Study Design A Data Collection B Analysis C Statistical Data Interpretation D Manuscript Preparation E Literature Search F Collection G Funds
ABCDEF 1 AC 1 AD 1,2 DEF 3 BDF 4 BD 5
AF 1
AF 1
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
MeSH Keywords:
Full-text PDF:
Aldona Mikaliūkštienė Kęstutis Žagminas Algirdas Juozulynas Laura Narkauskaitė Jonas Sąlyga Konstancija Jankauskienė Rimantas Stukas Genė Šurkienė
1 Faculty of Medicine, Vilnius University, Vilnius, Lithuania 2 Department of Innovative Diagnostic, Treatment and Health Technology, Institute of Innovative Medicine, Vilnius, Lithuania 3 Department of Research and Technology Assassment, Institute of Hygiene, Vilnius, Lithuania 4 Faculty of Health Science, University of Klaipėda, Klaipėda, Lithuania 5 Academy of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
Laura Narkauskaite, e-mail: [email protected] Departmental sources
Depression is associated with a variety of diabetes complications, including diabetic retinopathy, nephropathy, neuropathy, and macrovascular complications. The prevalence of the symptoms of anxiety (32%) and depression (22.4%) in patients with diabetes is considerably higher than in general population samples (10%). The aim of this study was to evaluate the prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes (T2DM). This survey was conducted during 2007-2010. In total, 1500 patients were invited to participate in the study. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety for the evaluation of the depressive state and anxiety. Statistical analysis was carried out using SPSS 17.0. More than 70% of all respondents who participated in the study had diabetes mellitus complications (72.2%). The prevalence of mild to severe depression score was 28.5% (95% CI 25.7–31.4). The prevalence of anxiety was 42.4% (95% CI 39.3–45.5). Anxiety was more frequent among females (46.8%) than among males (34.7%) (p
